Detalhe da pesquisa
1.
Milestoning estimators of dissipation in systems observed at a coarse resolution.
Proc Natl Acad Sci U S A
; 121(17): e2318333121, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38625949
2.
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
N Engl J Med
; 389(2): 148-157, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272527
3.
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
Blood
; 143(2): 152-165, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37832030
4.
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
N Engl J Med
; 386(7): 640-654, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34891224
5.
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
N Engl J Med
; 385(1): 46-58, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192431
6.
Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products.
Cytotherapy
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38819367
7.
Arsenate Anion-π Interactions on Amine-Modified Polydivinylbenzene in Aqueous Systems: Experimental and Theoretical Investigation.
Langmuir
; 40(2): 1150-1163, 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38165764
8.
Folding and misfolding of potassium channel monomers during assembly and tetramerization.
Proc Natl Acad Sci U S A
; 118(34)2021 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34413192
9.
Long-term outcomes following successful endoscopic treatment of T1 esophageal adenocarcinoma: a multicenter cohort study.
Gastrointest Endosc
; 98(5): 713-721, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356631
10.
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis.
Eur J Haematol
; 111(5): 815-823, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37574220
11.
The effect of time resolution on the observed first passage times in diffusive dynamics.
J Chem Phys
; 158(11): 111101, 2023 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36948823
12.
Non-Markov models of single-molecule dynamics from information-theoretical analysis of trajectories.
J Chem Phys
; 159(6)2023 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37551804
13.
A Consensus Diagnosis Utilizing Surface KI-67 Expression as an Ancillary Marker in Low-Grade Dysplasia Helps Identify Patients at High Risk of Progression to High-Grade Dysplasia and Esophaegal Adenocarcinoma.
Dis Esophagus
; 36(3)2023 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36190180
14.
Clinicopathological characteristics and long-term outcomes of plasmablastic lymphoma in British Columbia.
Br J Haematol
; 199(2): 230-238, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35961783
15.
Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database.
Br J Haematol
; 198(1): 93-102, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35383886
16.
Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohort.
Eur J Haematol
; 108(5): 437-445, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35122325
17.
Real-world outcomes with bortezomib-containing regimens and lenalidomide plus dexamethasone for the treatment of transplant-ineligible multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group database.
Br J Haematol
; 193(3): 532-541, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33559897
18.
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.
Br J Haematol
; 195(3): 388-398, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590303
19.
Retrospective study of treatment patterns and outcomes post-lenalidomide for multiple myeloma in Canada.
Eur J Haematol
; 107(4): 416-427, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34129703
20.
The impact of lenalidomide maintenance on second-line chemotherapy in transplant eligible patients with multiple myeloma.
Eur J Haematol
; 106(5): 673-681, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539037